Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy
Senast uppdaterad 18 aug 2020
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, usually called CADASIL, is an inherited condition that causes stroke and other impairments. This condition affects blood flow in small blood vessels, particularly cerebral vessels within the brain. The muscle cells surrounding these blood vessels (vascular smooth muscle cells) are abnormal and gradually die. In the brain, the resulting blood vessel damage (arteriopathy) can cause migraines, often with visual sensations or auras, or recurrent seizures (epilepsy).
Videoval för Genetiska tillståndVideobibliotek
Beskrivning
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, usually called CADASIL, is an inherited condition that causes stroke and other impairments. This condition affects blood flow in small blood vessels, particularly cerebral vessels within the brain. The muscle cells surrounding these blood vessels (vascular smooth muscle cells) are abnormal and gradually die. In the brain, the resulting blood vessel damage (arteriopathy) can cause migraines, often with visual sensations or auras, or recurrent seizures (epilepsy).
Damaged blood vessels reduce blood flow and can cause areas of tissue death (infarcts) throughout the body. An infarct in the brain can lead to a stroke. In individuals with CADASIL, a stroke can occur at any time from childhood to late adulthood, but typically happens during mid-adulthood. People with CADASIL often have more than one stroke in their lifetime. Recurrent strokes can damage the brain over time. Strokes that occur in the subcortical region of the brain, which is involved in reasoning and memory, can cause progressive loss of intellectual function (dementia) and changes in mood and personality.
Many people with CADASIL also develop leukoencephalopathy, which is a change in a type of brain tissue called white matter that can be seen with magnetic resonance imaging (MRI).
The age at which the signs and symptoms of CADASIL first begin varies greatly among affected individuals, as does the severity of these features.
CADASIL is not associated with the common risk factors for stroke and heart attack, such as high blood pressure and high cholesterol, although some affected individuals might also have these health problems.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.
Related genes
Other names
CADASIL
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy
Familial vascular leukoencephalopathy
Hereditary dementia, multi-infarct type
Related patient information and medicines

Patient information leaflet
Marfans syndrom
Marfans syndrom (named after Dr Antoine Marfan, the French doctor who first described it in 1896) is a genetic disorder which people are born with and which lasts lifelong. Marfans syndrom kan affect the connective tissue in different parts of your body, including your heart, blood vessels, eyes and skeleton. It is an autosomal dominant condition,.

Patient information leaflet
Subaraknoidalblödning
A subaraknoidalblödning (SAB) is a form of stroke in which bleeding occurs into the fluid-filled space surrounding the brain (called the subarachnoid space). It is usually caused by the rupture of a small berry-like swelling (called a berry aneurysm) on one of the arteries in the brain. Certain inherited conditions which cause weakening of the.

Patient information leaflet
CT-skanning
Note : the information below is a general guide only. The arrangements, and the way tests are performed, may vary between different hospitals. It also gives clear pictures of soft tissues, whi... Den most commonly performed CT scan is of the brain - to determine the cause of a stroke Stroke , or to assess serious head injuries. Other uses of a CT.

Patient information leaflet
Nästäppa
There have been rare reports of two conditions associated with pseudoephedrine use - posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstri... Following a review by MHRA - the safety information of all pseudoephedrine-containing medicines will be updated to provide clearer descriptions of these risks and potential.

Patient information leaflet
Diabetisk njursjukdom
Diabetisk njursjukdom is a complication that occurs in some people with diabetes. Also, it aims to reduce the risk of developing cardiovascular diseases such as heart attack and stroke which are much more common than average in people with this disease. Kardiovaskulär diseases All people with diabetes have an increased risk of developing.

Patient information leaflet
Avsvällande medel
Dr Krishna Vakharia , 21st February 2024 A note on pseudoephedrine-containing products. The Medicines and ... There have been rare reports of two conditions associated with pseudoephedrine use - posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). PRES- also known as reversible posterior.
Vidare läsning och referenser
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; MedlinePlus, National Library of Medicine.
- Coupland K, Lendahl U, Karlstrom H. Role of NOTCH3 Mutations in the Cerebral Small Vessel Disease Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy. Stroke. 2018 Nov;49(11):2793-2800. doi: 10.1161/STROKEAHA.118.021560. No abstract available.
- Cramer J, Lui F, White ML. Cerebral Autosomal Dominant Arteriopathy. 2024 Mar 21. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK470293/
- Felix-Ilemhenbhio F, Kocsy K, Azzouz M, Majid A. The role of NOTCH3 in CADASIL pathogenesis: insights into novel therapies. Brain Res. 2025 Sep 15;1863:149754. doi: 10.1016/j.brainres.2025.149754. Epub 2025 May 31.
- Ferrante EA, Cudrici CD, Boehm M. CADASIL: new advances in basic science and clinical perspectives. Curr Opin Hematol. 2019 May;26(3):193-198. doi: 10.1097/MOH.0000000000000497.
- Gatti JR, Zhang X, Korcari E, Lee SJ, Greenstone N, Dean JG, Maripudi S, Wang MM. Redistribution of Mature Smooth Muscle Markers in Brain Arteries in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. Transl Stroke Res. 2018 Jun 22:10.1007/s12975-018-0643-x. doi: 10.1007/s12975-018-0643-x. Online ahead of print.
- Hack RJ, Rutten J, Lesnik Oberstein SAJ. CADASIL. 2000 Mar 15 [updated 2019 Mar 14]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1500/
- Haritunians T, Boulter J, Hicks C, Buhrman J, DiSibio G, Shawber C, Weinmaster G, Nofziger D, Schanen C. CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand. Circ Res. 2002 Mar 22;90(5):506-8. doi: 10.1161/01.res.0000013796.73742.c8.
- Hosseini-Alghaderi S, Baron M. Notch3 in Development, Health and Disease. Biomolecules. 2020 Mar 23;10(3):485. doi: 10.3390/biom10030485.
- Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996 Oct 24;383(6602):707-10. doi: 10.1038/383707a0.
- Mizuno T, Mizuta I, Watanabe-Hosomi A, Mukai M, Koizumi T. Clinical and Genetic Aspects of CADASIL. Front Aging Neurosci. 2020 May 7;12:91. doi: 10.3389/fnagi.2020.00091. eCollection 2020.
- Opherk C, Peters N, Herzog J, Luedtke R, Dichgans M. Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain. 2004 Nov;127(Pt 11):2533-9. doi: 10.1093/brain/awh282. Epub 2004 Sep 13.
- Wang MM. CADASIL. Handb Clin Neurol. 2018;148:733-743. doi: 10.1016/B978-0-444-64076-5.00047-8.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
18 aug 2020 | Senaste versionen
1 May 2008 | Ursprungligen publicerad
Dela dina tankar eller erfarenheter med andra i vår patientgemenskaper.
Anmäl dig till Patientens nyhetsbrev
Din veckovisa dos av tydliga, pålitliga hälsoråd - skrivna för att hjälpa dig känna dig informerad, självsäker och i kontroll.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.

